TGFB1 and early-onset autosomal dominant Alzheimer disease: Although TGF-β1 is traditionally characterized as an anti-inflammatory cytokine, elevated CSF levels of TGF-β1 are present in people with Alzheimer’s disease [51] and in PWH [52,53], supporting a possible negative effect of excessive levels in the brain.